Fred Hutch Cancer Center researchers are seeking better ways to prevent, detect and treat kidney cancer. We are also working to better understand the factors that affect each person’s risk for this cancer. Our scientists are also developing new methods to gauge how well a tumor will respond to treatment.
Researchers at Fred Hutch are running many clinical trials of new drugs and drug combinations to treat different types of kidney cancer. These experimental therapies are part of a trend toward precision cancer care. The idea behind precision care is to target a patient’s tumor based on its molecular profile. We continue to hunt for more potential targets on kidney cancer cells that could lead to even more treatment options.
Kidney Cancer Clinical Trials
Fred Hutch typically has over 750 active cancer clinical trials enrolling participants.
Clinical trials may allow some patients access to a promising new treatment, and help physicians and researchers learn more about a disease.
Our Kidney Cancer Researchers and Faculty
Our scientists and providers work together to prevent, diagnose and treat kidney cancer as well as other cancers and diseases. The lab research and clinical research they do are essential parts of the scientific process that leads to new treatments and better care. Many of our kidney cancer providers do research in addition to seeing patients. Clinical trials can also be a way for patients to get early access to new leading-edge therapies. Our research teams are running many clinical studies for people with kidney cancer.
See below for our researchers and faculty or view our kidney cancer care team providers.
K. Scott Baker, MD, MS
K. Scott Baker, MD, MS
Professor, Clinical Research Division, Fred Hutch
Joint Professor, Public Health Sciences Division, Fred Hutch
3 more appointments
Shailender Bhatia, MD
Shailender Bhatia, MD
Professor, Clinical Research Division, Fred Hutch
Member, Pathogen-Associated Malignancies Integrated Research Center (PAM IRC)
3 more appointments
Christopher D. Blosser, MD
Christopher D. Blosser, MD
Professor, Clinical Research Division, Fred Hutch
Director, Cancer and Organ Transplant Clinic, Fred Hutch
4 more appointments
Delphine Chen, MD
Delphine Chen, MD
Professor, Clinical Research Division, Fred Hutch
Director, Molecular Imaging and Therapy, Fred Hutch
3 more appointments
Lawrence Fong, MD
Lawrence Fong, MD
Scientific Director, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
Professor, Translational Science and Therapeutics Division, Fred Hutch
5 more appointments
Lab Website
John L. Gore, MD, MS, FACS
John L. Gore, MD, MS, FACS
Senior Vice President and Director, Surgical Oncology Division, Fred Hutch
5 more appointments
Evan Hall, MD, MPhil
Evan Hall, MD, MPhil
Associate Professor, Clinical Research Division, Fred Hutch
Omar Mian, MD, PhD
Omar Mian, MD, PhD
Associate Professor, Human Biology Division, Fred Hutch
Associate Professor, Precision Radiation Sciences Lead, Radiation Oncology Division, Fred Hutch
1 more appointment
Lab Website
Ramesh Rengan, MD, PhD
Ramesh Rengan, MD, PhD
Senior Vice President and Director, Radiation Oncology Division, Fred Hutch
Member, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
3 more appointments
Michael Schweizer, MD
Michael Schweizer, MD
Professor, Clinical Research Division, Fred Hutch
Member, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
3 more appointments
Scott Tykodi, MD, PhD
